ClinicalTrials.gg
WithdrawnNCT00849589Updated Oct 7, 2016

Computerized Screening and Brief Physician Advice to Reduce Teen Drinking

An interventional study of Computerized screening and brief physician advice and Computerized SBA with technological extenders in Alcohol Abuse and Risk Behavior, sponsored by Boston Children's Hospital. Withdrawn at 1 site in United States. Open to participants aged 12 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-07.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Screening

Why this study was withdrawn
Grant application was not funded
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
12 Years to 21 Years
Sex
All
01

Study summary

The goal of this project is to adapt a computerized Screening and Brief Advice (SBA) protocol that has demonstrated efficacy in reducing underage drinking among adolescent primary care patients and then to test it in a multi-site randomized controlled trial (RCT).

Read the detailed description

The specific aims of the proposed multisite RCT are:

  1. To establish the efficacy of the computerized SBA protocol on alcohol use, on DWI/RWID, and other alcohol-related health risk behaviors;
  2. To test the effect of Technological Extenders (TE) on prolonging the beneficial effects of the SBA protocol;
  3. To identify moderators, mediators, and optimal responders to the SBA/TE interventions;
  4. To examine the association between cessation of underage drinking and other health-risk behaviors in an adolescent primary care sample.
02

Conditions studied

  • Alcohol Abuse
  • Risk Behavior

Keywords

  • Screening
  • Brief intervention
  • Underage drinking
03

In context

Alcoholism

1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.

Browse Alcoholism studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 147 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 12-21 years old
  • patients arriving for routine medical care
  • provide informed assent (for those \<18) or (for those 18-21)

Exclusion criteria

Exclusion Criteria:

  • medically or psychologically unstable at time of visit
  • receiving behavioral health services
  • cannot read or understand English at a 6th grade reading level
  • unavailable for follow-up assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    1

    Treatment as Usual (TAU)

  • Experimental
    2

    Computerized Screening and Brief Physician Advice (SBA)

    Behavioral: Computerized screening and brief physician advice

  • Experimental
    3

    Computerized screening and brief physician advice with technological extenders (SBA/TE)

    Behavioral: Computerized SBA with technological extenders

Interventions

  • BehavioralComputerized screening and brief physician advice

    Participants complete screening for alcohol use and other health risk behaviors on the computer, receive some related health information on the computer, and meet with a primary care provider for a short discussion of health risk behaviors

    Also known as: Screening, Brief advice, Brief intervention, Underage drinking

  • BehavioralComputerized SBA with technological extenders

    Participants complete screening for alcohol use and other health risk behaviors on the computer, receive some related health information on the computer, and meet with a primary care provider for a short discussion of health risk behaviors. In addition, the provider sends them a brief email or text message at 4 months and 9 months after study entry to reinforce the brief advice.

    Also known as: Screening, Brief advice, Brief intervention, Underage drinking

06

What researchers measure

Primary outcomes

  1. Initiation of underage drinking

    Time frame: Baseline, 3-months, 6-months, 12-months

Secondary outcomes

  1. Cessation of underage drinking

    Time frame: Baseline, 3-months, 6-months, 12-months

07

Study locations

1 site
  • Children's Hospital Boston
    Boston, Massachusetts 02115, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00849589
Collaborators
Cambridge Health Alliance, Dartmouth-Hitchcock Medical Center, Fallon Clinic, Tufts Medical Center, University of Vermont
Responsible party
John R Knight, MD (Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital, Boston Children's Hospital) — Principal investigator
First posted
Feb 24, 2009
Start date
Jan 2010
Primary completion
Jan 2014 (estimated)
Completion
Dec 2014 (estimated)
Last update
Oct 7, 2016

Study contacts

John R. Knight, MD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion